Press Releases

Filter by Category

Filter by Program

Filter by Publish Date

September 11, 2025

C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics

Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...

September 8, 2025

C-Path today announced the election of Ronald J. Bartek to its Board of Directors.

September 4, 2025

Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million in 2025

August 21, 2025

TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium (HD

August 19, 2025

TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded a

August 7, 2025

TUCSON, Ariz., Aug. 7, 2025 ⎯ Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator

August 7, 2025

TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded

July 22, 2025

Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...

July 16, 2025

C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...

July 16, 2025

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....